SUMOylation is required for optimal TRAF3 signaling capacity

PLoS One. 2013 Nov 18;8(11):e80470. doi: 10.1371/journal.pone.0080470. eCollection 2013.

Abstract

TNF receptor-associated factors (TRAFs) are multifunctional adaptor proteins involved in temporal and spatial coordination of signals necessary for normal immune function. Here, we report that TRAF3, a TRAF family member with a key role in Toll-like and TNF family receptor signaling and suppressor of lymphomagenesis, is post-translationally modified by the small ubiquitin-related modifier (SUMO). Through yeast two-hybrid and co-immunoprecipitation assays we have identified Ubc9, the SUMO conjugating enzyme, as a novel TRAF3-interacting protein. We show that Ubc9-dependent SUMOylation of TRAF3 modulates optimal association with the CD40 receptor, thereby influencing TRAF3 degradation and non-canonical NF-κB activation upon CD40 triggering. Collectively, our findings describe a novel post-translational modification of a TRAF family member and reveal a link between SUMOylation and TRAF-mediated signal transduction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD40 Antigens / metabolism
  • Cell Transformation, Neoplastic / metabolism
  • Humans
  • Lymphoma / metabolism
  • NF-kappa B p52 Subunit / metabolism
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Interaction Mapping / methods
  • Proteolysis
  • Signal Transduction*
  • Sumoylation
  • TNF Receptor-Associated Factor 3 / metabolism*
  • Two-Hybrid System Techniques
  • Ubiquitin-Conjugating Enzymes / metabolism

Substances

  • CD40 Antigens
  • NF-kappa B p52 Subunit
  • TNF Receptor-Associated Factor 3
  • Ubiquitin-Conjugating Enzymes
  • ubiquitin-conjugating enzyme UBC9

Grants and funding

This work was supported by the European Commission FP6 and FP7 programmes Apotherapy (EC contract number 037344), INFLA-CARE (EC contract number 223151) and 'Translational Potential' (TransPOT; EC contract number 285948) to Aristides Eliopoulos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.